Tryptamine has firm commitments to raise $6m in a placement to advance clinical development of its novel IV-infused psilocin ...

Several drug classes - including amphetamines, tryptamines, and psychedelics - have been shown to promote plasticity, however, these first-generation compounds may induce profound psychoactive ...

Tryptamine Therapeutics (AU:TYP) has released an update. Tryptamine Therapeutics is undergoing a strategic board reshuffle as Non-Executive Director Peter Molloy steps down, paving the way for Dr ...

Rockville, MD, Nov. 06, 2024 (GLOBE NEWSWIRE) -- According to a new industry report by Fact.MR, the global tryptamine API market is projected to be worth US$ 757.2 million in 2024 and thereafter ...

I spent three days going through Heart of Darkness with Rebind's AI reading platform. It felt like a book club for deep thinkers. Carly Quellman is a movement artist, storyteller and disability ...

and institutional investors to raise $6 million to accelerate development of its novel IV-infused psilocin formulation TRP-8803. Tryptamine Therapeutics (ASX:TYP) said the placement was being ...